Louisiana State Employees Retirement System Lowers Holdings in DaVita Inc. (NYSE:DVA)

Louisiana State Employees Retirement System trimmed its holdings in DaVita Inc. (NYSE:DVA) by 7.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 2,400 shares of the company’s stock after selling 200 shares during the period. Louisiana State Employees Retirement System’s holdings in DaVita were worth $359,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Transcendent Capital Group LLC purchased a new position in shares of DaVita during the third quarter worth $25,000. Blue Trust Inc. boosted its position in shares of DaVita by 56.4% during the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after buying an additional 119 shares during the period. Quarry LP purchased a new position in shares of DaVita during the third quarter worth $60,000. Versant Capital Management Inc boosted its position in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after buying an additional 169 shares during the period. Finally, Wingate Wealth Advisors Inc. purchased a new position in shares of DaVita during the fourth quarter worth $82,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

DaVita Stock Down 0.1 %

Shares of NYSE DVA opened at $154.84 on Thursday. The stock has a market cap of $12.39 billion, a P/E ratio of 14.42, a PEG ratio of 0.79 and a beta of 0.94. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 12-month low of $119.42 and a 12-month high of $179.60. The business’s fifty day simple moving average is $161.40 and its 200-day simple moving average is $157.89.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities analysts predict that DaVita Inc. will post 10.93 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Barclays increased their price objective on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, DaVita presently has an average rating of “Hold” and a consensus price target of $162.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.